The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study.
Saved in:
| Title: | The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study. |
|---|---|
| Authors: | Klein A; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, München, Germany., Flaskamp M; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, München, Germany., Berthele A; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, München, Germany., Held F; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, München, Germany., Muratovic H; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, München, Germany., Hemmer B; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaninger Str. 22, München, 81675, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. |
| Source: | Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2023 Apr 17; Vol. 16, pp. 17562864231162661. Date of Electronic Publication: 2023 Apr 17 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1756-2856 |
|---|---|
| DOI: | 10.1177/17562864231162661 |
